Verubecestat (TFA)
Verubecestat (MK-8931) TFA is an orally active, high-affinity BACE1 and BACE2 inhibitor with Ki values of 2.2 nM and 0.38 nM. Verubecestat TFA effectively reduces Aβ40 and has the potential for Alzheimer's Disease[1][2].
Product Specifications
Product Name Alternative
MK-8931 (TFA)
UNSPSC
12352005
Hazard Statement
H302-H315-H319-H335
Target
Beta-secretase
Type
Reference compound
Related Pathways
Neuronal Signaling
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/verubecestat-tfa.html
Purity
98.32
Solubility
DMSO : 35 mg/mL (ultrasonic; warming)
Smiles
O=C(C1=NC=C(C=C1)F)NC2=CC=C(C([C@@](C)(N=C(N3C)N)CS3(=O)=O)=C2)F.O=C(C(F)(F)F)O
Molecular Formula
C19H18F5N5O5S
Molecular Weight
523.43
Precautions
P261-P264-P270-P271-P280-P302+P352-P304+P340-P330-P362+P364-P405-P501
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-16759A/Verubecestat-TFA-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-16759A/
Scientific Category
Reference compound1
Clinical Information
Phase 3
CAS Number
[2095432-65-6]
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
